Search - tctmd.com

Displaying 901 - 920 of 1758

Sort: Relevancy | Date

Presentation TCT 2017

The DES Landscape and Bioabsorbable Scaffolds in 2017

Presenter: Debabrata Mukherjee, E. Murat Tuzcu, Giulio G. Stefanini

November 01, 2017

Presentation TCT 2017

Flash Debate: If Anything, Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should be Downgraded Based on EXCEL and NOBLE!

Presenter: Sanjay Kaul, Tullio Palmerini, Jacek Legutko

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

Presenter: David J. Maron, Alan C. Yeung, Michael E. Farkouh

November 01, 2017

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms IV

Presenter: C. Michael Gibson, Shelley Wood, Robert W. Yeh

November 01, 2017

Presentation TCT 2017

Flash Debate: Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should Be Upgraded to Class I Based on EXCEL and NOBLE!

Presenter: Sanjay Kaul, Tullio Palmerini, Evald H. Christiansen

November 01, 2017

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms III

Presenter: C. Michael Gibson, Shelley Wood, Sunil V. Rao

November 01, 2017

Presentation TCT 2017

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung

November 01, 2017

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms II

Presenter: C. Michael Gibson, Shelley Wood

November 01, 2017

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms I

Presenter: C. Michael Gibson, Shelley Wood, Mirvat Alasnag

November 01, 2017

Presentation TCT 2017

Flash Debate: Registry Data and Personal Experiences Are Strong Enough to Justify Frequent Use of IMPELLA in High-Risk PCI and Cardiogenic Shock!

Presenter: Sanjay Kaul, Tullio Palmerini, Dimitri Karmpaliotis

November 01, 2017

Presentation TCT 2017

Is There a Preferred Stent for the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Upendra Kaul

November 01, 2017

Presentation TCT 2017

Optimizing the Acute and Chronic Use of Antiplatelet and Antithrombotic Agents (and Their Combination): 2017 Update

Presenter: Debabrata Mukherjee, E. Murat Tuzcu, Dimitrios Alexopoulos

November 01, 2017

Presentation TCT 2017

Flash Debate: There Is Insufficient Evidence From Randomized Trials to Justify Frequent Use of Impella in High-Risk PCI and Cardiogenic Shock!

Presenter: Sanjay Kaul, Tullio Palmerini, Holger Thiele

November 01, 2017

Presentation TCT 2017

When Should PCI Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Sripal Bangalore

November 01, 2017

Presentation TCT 2017

Seeing Better Is Doing Better: Augmented Reality to Enhance Interventional Cardiology Procedures

Presenter: Gary S. Mintz, Giora Weisz, Maksymilian P. Opolski

November 01, 2017

Presentation TCT 2017

Flash Debate: FFR/iFR in ACS Patients With MVD There is Little Credible Evidence on Which to Base Any Recommendations!

Presenter: Sanjay Kaul, Tullio Palmerini, Francesco Saia

November 01, 2017

Presentation TCT 2017

When Should CABG Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Jack Boyd

November 01, 2017

Presentation TCT 2017

Twitter, Facebook, and Instagram 101: The Basics

Presenter: C. Michael Gibson, Shelley Wood, Sheila Sahni

November 01, 2017

Presentation TCT 2017

Worldwide Deaths and MI From Coronary Atherosclerosis: Scope of an Epidemic

Presenter: John A. Ambrose, Y. S. Chandrashekhar, James E. Muller

November 01, 2017

Presentation TCT 2017

Flash Debate: FFR/iFR in ACS Patients With MVD - Based on the Evidence the Guidelines are Justified and Should Be Even Stronger!

Presenter: Sanjay Kaul, Tullio Palmerini, Tim P. van de Hoef

November 01, 2017

Advertisement

The DES Landscape and Bioabsorbable Scaffolds in 2017

Flash Debate: If Anything, Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should be Downgraded Based on EXCEL and NOBLE!

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

Case Examples of Interventionalists Social Medial Platforms IV

Flash Debate: Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should Be Upgraded to Class I Based on EXCEL and NOBLE!

Case Examples of Interventionalists Social Medial Platforms III

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Case Examples of Interventionalists Social Medial Platforms II

Case Examples of Interventionalists Social Medial Platforms I

Flash Debate: Registry Data and Personal Experiences Are Strong Enough to Justify Frequent Use of IMPELLA in High-Risk PCI and Cardiogenic Shock!

Is There a Preferred Stent for the Diabetic Patient?

Optimizing the Acute and Chronic Use of Antiplatelet and Antithrombotic Agents (and Their Combination): 2017 Update

Flash Debate: There Is Insufficient Evidence From Randomized Trials to Justify Frequent Use of Impella in High-Risk PCI and Cardiogenic Shock!

When Should PCI Be Preferred in the Diabetic Patient?

Seeing Better Is Doing Better: Augmented Reality to Enhance Interventional Cardiology Procedures

Flash Debate: FFR/iFR in ACS Patients With MVD There is Little Credible Evidence on Which to Base Any Recommendations!

When Should CABG Be Preferred in the Diabetic Patient?

Twitter, Facebook, and Instagram 101: The Basics

Worldwide Deaths and MI From Coronary Atherosclerosis: Scope of an Epidemic

Flash Debate: FFR/iFR in ACS Patients With MVD - Based on the Evidence the Guidelines are Justified and Should Be Even Stronger!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content